NEW YORK (GenomeWeb News) – MDS said today that it has notified the Toronto Stock Exchange that it may purchase up to roughly 5 percent of the float of its public stock on the TSE and New York Stock Exchange during the next year.

The Toronto-based firm said that during the 12 months commencing July 3, 2008, and ending July 2, 2009, it may purchase up to 4,136,766 MDS common shares on the two exchanges.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.